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Abstract
There are established racial disparities in healthcare, including during end-of-life care,
when poor communication and trust can lead to suboptimal outcomes for patients and
their families. In this work, we find that racial disparities which have been reported in
existing literature are also present in the MIMIC-III database. We hypothesize that one
underlying cause of this disparity is due to mistrust between patient and caregivers, and we
develop multiple possible trust metric proxies (using coded interpersonal variables and clin-
ical notes) to measure this phenomenon more directly. These metrics show even stronger
disparities in end-of-life care than race does, and they also tend to demonstrate statisti-
cally significant higher levels of mistrust for black patients than white ones. Finally, we
demonstrate that these metrics improve performance on three clinical tasks: in-hospital
mortality, discharge against medical advice (AMA) and modified care status (e.g., DNR,
DNI, etc.).
1. Introduction
There are well-established gaps in the American healthcare system for minority populations:
white Americans live 4.5 years longer than African Americans (Arias, 2014), infant mortality
rates are twice as high for African Americans even after adjusting for socioeconomic status
(Ely et al., 2017), African American men are 50% more likely to develop prostate cancer
than white men and are twice as likely to die from it (CDC, 2014). Differences in care also
persist during end-of-life (Muni et al., 2011; Lee et al., 2016).
Previous work has suggested that some treatment and outcome disparities are related
to higher levels of mistrust: some African Americans have shown suspicion of the clinical
motives in advance directives and do-not-resuscitate (DNR) orders (Wunsch et al., 2010),
and some report that they suspect that the healthcare system was limiting which treat-
ments they could receive (Perkins et al., 2002). Mistrust between patient and clinician can
be detrimental to patient care, especially in end-of-life (EOL), when patients might defy
physician recommendations and insist on higher levels of aggressive care. This would be
especially problematic because aggressive EOL care can lead to painful final moments and
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may not improve patient outcomes (Cipolletta and Oprandi, 2014). In this work, we turn
to a novel source for estimating a patient and clinician’s trust relationship: clinical notes
and documented interpersonal features. Prior work has established the importance of notes
in prediction tasks (Ghassemi et al., 2014, 2015; Suresh et al., 2017), but not in quantify-
ing mistrust. Further, while others have worked to establish variations in care in private
datasets (Pritchard et al., 1998; Levinsky et al., 2001; Gessert et al., 2001), we target the
publicly-available MIMIC dataset (Johnson et al., 2016) to emphasize reproducibility and
encourage future work in this area 1.
We provide three contributions:
∙ We quantify the racial disparities in EOL care in the publicly-available MIMIC dataset,
and make data extraction and modeling code available for reproduction.2
∙ We propose multiple proxy trust scores to study the inherent mistrust that patients
have in clinical staff providing their care.
∙ We demonstrate that our trust scores improve performance in three care-based classifi-
cation tasks: in-hospital mortality, leaving the hospital against medical advice (AMA),
and care status (e.g. Do Not Resuscitate).
2. Background and Related Work
2.1 Medical Treatment Gap
There are well-established biases in clinical care that follow social biases. For instance,
women (Hoffmann and Tarzian, 2001) and obese patients (Phelan et al., 2015) often have
worse treatment options and worse outcomes. Racial disparities have been demonstrated in
many care settings; African Americans are less likely to receive pain medication than their
white counterparts, even when controlling for covariates such as age, sex, and time of treat-
ment Goyal et al. (2015); Singhal et al. (2016). Doctors are more likely to diagnose African
Americans with more severe disorders (e.g., schizophrenia and other psychotic disorders),
yet less likely to diagnose them with depression Simon et al. (1973); Adebimpe (1981); Ruiz
(1983). Biases are especially troubling when applying machine learning because the model
might identify and exacerbate biases in a feedback loop (Ensign et al., 2017). However,
some select clinical tasks do benefit from knowing the patient’s race (e.g. when there are
differences in recommended care by genetic makeup). In such settings, race should not be
ignored, but algorithms must take steps to reduce unnecessary bias.
2.2 End-of-Life Care Differences
During EOL care, minorities are more likely to receive high-intensity, life-sustaining treat-
ments (Pritchard et al., 1998; Levinsky et al., 2001; Gessert et al., 2001) and have fewer
advance directives3 (Smith et al., 2008). White patients are more likely to utilize hospice
care and are less likely to disenroll in it than non-white patients (Garrett et al., 1993; Hopp
and Duffy, 2000). While some of these differences may be attributed to cultural preferences,
many issues can also be the result of poor communication or unclear expectations. These
1We note that further analysis is available in Boag (2018).
2https://github.com/wboag/eol-mistrust
3An advance directive is a legal document that can help ensure patient preferences for various medical
treatments are followed if they become incapable of making healthcare decisions.
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imbalances are potentially harmful because aggressive care does not always lead to improved
patient outcomes (Cipolletta and Oprandi, 2014).
2.3 Medical Mistrust Among Minority Communities
Recent work has explored the multi-faceted history of mistrust between the African Amer-
icans community and medical institutions (Washington, 2007). Poor trust can specifically
impact end-of-life care; family members of African American patients are more likely to cite
absent or problematic communication with physicians about EOL care (Hauser et al., 1997).
Similarly, surveyed African Americans report lower rates of satisfaction with received quality
of care (Hanchate et al., 2009). Mistrust can potentially help understand racial disparities
in aggressive treatments such as mechanical ventilation and vasopressors. When further in-
vasive procedures are unlikely to succeed or return the patient to a normal lifestyle, doctors
may recommend withdrawing treatment and transitioning to comfort-based measures to en-
sure the patient does not suffer. However, mistrust may lead a patient or healthcare proxy
to question the intention of the assessment (e.g. the hospital doesn’t want to use resources),
and instead demand more aggressive interventions (Garrett et al., 1993; Hopp and Duffy,
2000).
2.4 Quantifying Trust
Trust is shaped by subtle interactions in perceived discrimination, racial discordance, poor
communication, language barriers, unsatisfied expectations, cultural stigmas and reputa-
tions, and is therefore difficult to quantify (L. Whaley, 2001). However, trust is a crucial
part of medical care; increased levels of doctor-patient trust have been associated with
stronger adherence to a physician’s advice and improved health status (Gelb Safran et al.,
1998). Previous efforts to create trust-based measures that correlate with outcomes have
relied on surveys, which can be difficult to conduct for both methodological (e.g., selection
bias) and practical (e.g., de-identification) reasons (Lee et al., 2016).
3. Data
3.1 Data Source
We use the MIMIC-III v1.4 (Johnson et al., 2016) database, consisting of de-identified EHR
data from over 58,000 hospital admissions for nearly 38,600 adult patients. The data was
collected from Beth Israel Deaconess Medical Center from 2001–2012.
We define two cohorts from MIMIC: EOL (11,000 admissions) and ALL (50,000 admis-
sions). We use the EOL cohort to replicate racial disparities in MIMIC that other studies
have observed (Perry et al., 2013). We use the ALL cohort to develop a metric to score the
signs of mistrust in each patient’s hospital stay and to predict non-end-of-life clinical tasks.
Both our data extraction and modeling code are made available to promote reproducibility
and further study (Johnson et al., 2017).
A patient is added to the EOL cohort if they have a hospital stay which lasted at least
6 hours and they either died in the hospital, were discharged to hospice, or were discharged
to a skilled nursing facility4. Table 1 displays summary statistics of the cohort by race.
4See the extended masters thesis (Boag, 2018) for additional analysis. Disparities are also replicated on
the eICU database, and all results are also performed on a stricter-but-smaller cohort that excludes skilled
nursing facilities.
3
Boag
Table 1: Population characteristics by race. Parenthetical numbers for categorical variables
denote % membership. Bracketed numbers for continuous variables denote 95% confidence
intervals.
Variable Value Black White p-value
Population Size 1214 9987 – – – – –
Insurance Private 141 (11.61%) 1594 (15.96%) < 0.001
Public 1062 (87.48%) 8356 (83.67%)
Self-Pay 11 ( 0.91%) 37 ( 0.37%)
Discharge Location Deceased 401 (33.03%) 3869 (38.74%) < 0.001
Hospice 40 ( 3.29%) 421 ( 4.22%)
Skilled Nursing Facility 773 (63.67%) 5697 (57.04%)
Gender F 733 (60.38%) 5012 (50.19%) < 0.001
M 481 (39.62%) 4975 (49.81%)
Length of stay 13.90 [5.55,19.56] 14.08 [6.45,19.45] 0.222
Age 71.31 [60.21,80.36] 77.87 [66.61,84.93] < 0.001
A 𝜒2 test shows significant differences for insurance type, discharge location, and gender
(𝑝 < 0.001 for all three). In particular, we see that the black population has both higher
rates of uninsurance and publicly-funded insurance than their white counterparts. In lieu of
other coded data, this often serves as a proxy for socio-economic status. In addition, white
patients have higher in-hospital mortality and hospice rates, whereas a larger percent of
black patients are discharged to skilled nursing facilities. Finally, there is a large difference
between the black gender ratio (60-40 women) and white gender ratio (50-50). Using the
Mann-Whitney test, the two populations have comparable lengths-of-stay (p=0.222), but
significantly different population ages (𝑝 < 0.001).
3.2 Treatment Extraction
The main focus for this work is measuring disparities in aggressive end-of-life procedures, so
we extract treatment durations (in minutes) from MIMIC’s derived mechanical ventilation
(ventdurations) and vasopressor (vasopressordurations) tables. Due to the noisiness of
clinical measurements – for instance, when one treatment span is erroneously coded as two
back-to-back smaller spans – we merge any treatment spans that occurred within 10 hours of
each other.5 If a patient had multiple spans, such as an intubation-extubation-reintubation,
then we consider the patient’s treatment duration to be the sum of the individual spans.
3.3 Patient-Provider Interaction Extraction
In this work, we quantify the patient’s interactions with their nurses and doctors using two
sources: clinical notes and coded chart events. We obtain the notes of any patient who had
a stay at least 12 hours in the ICU. This resulted in 48,273 admissions and over 800,000
notes. Throughout a patient’s stay, caregivers write narrative prose notes to document
5This heuristic was suggested by MIMIC staff because 10 hours is approximately the shift of a nurse,
and treatment duration events might get recorded once at the beginning of each shift.
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Table 2: Coded interpersonal feature types from chartevents.
1:1 sitter present? baseline pain level (0 to 10) received bath? bedside observer
behavioral intervent currently experiencing pain disease state consults
education barrier education learner education method feamily meeting?
education readiness harm by partner? education topic judgement
follows commands? family communication method gcs - verbal response informed?
hair washed? goal richmond-ras scale headache? health care proxy?
pain management non-violent restraints? orientation pain (0 to 10)
pain assess method understand & agree with plan? pain level acceptable? reason for restraint
restraint device richmond-ras scale (-5 to +4) rsbi deferred riker-sas scale
safety measures violent restraints ordered? security security guard
side rails status and comfort sitter skin care?
spiritual support behavior during application support systems stress
verbal response teaching directed toward wrist restraints? social work consult?
administered care, record patient preferences, issue reminders and warnings, and comment
on the patient’s quality of care. In documenting their impressions, caregivers can give clues
into the level of trust in their relationship with their patient. To supplement this narrative
prose, we also extract coded information from the MIMIC chartevents table. Table 2
shows the chartevents information types, with categories including: indication of family
meetings, patient education, whether the patient needed to be restrained, how thoroughly
pain is being monitored and treated, healthcare literacy (e.g. whether the patient has a
healthcare proxy), whether the patient has a support system (such as family, social workers,
and religion), and Riker-SAS (RR et al., 1999) and Richmond-RAS (Sessler et al.) agitation
scales.
4. Methods
4.1 Quantifying Racial Disparities in End-of-Life Care
We aim to replicate previous findings of racial disparities using MIMIC-III. We take as
reference a set of three recent papers which examined the racial disparities in end-of-life
care for non-white or minority populations (Yarnell et al., 2017; Muni et al., 2011; Lee
et al., 2016). We compared the median differences between white and black populations
using Mann-Whitney analysis. In accordance with prior work, we consider p-values of < .05
to be statistically significant.
4.2 Establishing a Medical Mistrust Metric
We aim to quantify trust in the doctor-patient relationship. Because it is novel to study
the effects of algorithmically-derived trust scores, we employ three metrics to avoid the
impression that any single one tells the whole story. Much like fairness, trust may eventually
prove to be impossible to fully characterize with a single score (Gajane and Pechenizkiy,
2018). Either way, we recommend that these scores be taken as a collective proxy for
further-refined notions of trust. Two of the scores come from training a model to predict
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Figure 1: An example of a nursing note documenting mistrust (in red). Situation-specific
identifying information has been blacked out.
trust-associated labels using interpersonal doctor-patient features, and the third score is
out-of-the-box sentiment analysis of the patient’s clinical notes.
For the first two metrics, we use an L1-regularized logistic regression to predict labels
derived from clinical notes using structured event data. The features in this predictive
framework were extracted for the ALL cohort from the chartevents table, as shown in
Table 2. In total, we extract 620 binary features.
Figure 1 shows an example of the various signals of mistrust that are documented in
nursing notes. We define two sets of trust-associated labels to train the above classifier
using simple rule-based searches to detect:
1. Noncompliance: Noncompliance (e.g. refusing to adhere to follow-ups, regiments,
take medicine, etc) indicates a very overt mistrust; rather than just holding an unspo-
ken resentment, the patient actually defies their doctor’s orders. It explicitly demon-
strates that the patient is willing to disregard physician decisions
2. Autopsy: One obvious benefit of an autopsy is quality assurance: did patient receive
the proper treatment for the proper disease? Often times, families decline autopsies
because they feel that dissecting a loved one would not be worth it when they trust that
the doctor did everything they could. Conversely, higher autopsy rates could indicate
patients suspect the doctor made a mistake. In this dataset, black patients (38.5%
autopsy rate) are autopsied much more often than white patients (24.3% autopsy rate).
Once these model are trained, we use each classifier’s predicted probability as a measure of
their mistrust for a new patient. This score defines a spectrum of trust based on how many
indicators the patient has that are associated with typically poor interactions vs typically
good interactions.
To encourage diversity of possible metrics, the third notion of mistrust is defined as the
negative of the sentiment score from the patient’s clinical notes in the caregiver’s own words.
We use the Pattern software package (De Smedt and Daelemans, 2012) and concatenate all
of the notes from the stay into one document and tokenized using whitespace as a delimiter.6
Finally, we normalize each of the mistrust score distributions to be zero-mean and unit-
variance, which helps for comparison.
6This step is actually important because a naive application of tokenization results in even positive
notes which contain identified tags like “Date:[**5-1-18**]” to be tagged as negative because the tool’s
string-matching algorithm was identifying “:[” as negative emoticon.
6
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4.3 Prediction of Downstream Clinical Outcomes
Trust is vital to a healthy doctor-patient relationship. A mistrustful patient might be re-
luctant to share sensitive, but potentially important information with their doctor. To
further explore the impact of modeled trust, we examine two trust-associated outcomes
(Code Status7 and Whether the patient leave Against Medical Advice (AMA)) and
one more standard outcome (in-hospital mortality). We are interested to see how much
value race and trust add as features to a baseline model which uses the patient’s age, gender,
length-of-stay, and insurance type. We take the average AUCs of 100 runs from randomly
chosen 60/40 train/test splits with an L1-regularized logistic regression model.
5. Results
5.1 Racial Treatment Disparities in EOL Care are Significant
We demonstrate racial treatment disparities in the MIMIC dataset do exist. Figure 2 high-
lights the differences in white and black populations for aggressive treatment durations.
Figures 2a and 2b show that for both mechanical ventilation and vasopressors, the median
black patient receives a longer duration of treatment, suggesting a reluctance to transi-
tion to palliative care. While these results only show statistical significance for ventilation
(p=0.005), the same trends are also observable for vasopressor administration (p=0.12) .
Figure 2: We observe racial disparities in aggressive interventions for black patients com-
pared to white patients. Medians are indicated by dotted lines; differences are significant
(𝑝 < 0.05) for ventilation but not for vasopressors.
(a) CDF of ventilation
duration by race (𝑝 = .005).
(b) CDF of vasopressor
duration by race (𝑝 = 0.12).
5.2 Quantifying Mistrust Better Captures EOL Treatment Disparities
5.2.1 Creation of a Mistrust Metric
Table 3 shows the three most positively and most negatively informative weights in each
model learned while fitting a mistrust metric. The features align well with an intuitive
notion of mistrust: patients who are agitated, restrained, and unreceptive to education are
7either “Full Code” or “DNR / DNI / Comfort Measures Only”
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more likely to be mistrustful. Conversely, we see that calm, pain-free patients with good
communication are more willing to trust their doctor.
5.2.2 Black Patients Have Higher Levels of Mistrust
We observe statistically significant racial disparities in the two-out-of-three mistrust metrics.
For both noncompliance-derived mistrust and negative sentiment, the median black patient
has a higher level of mistrust than the median white patient using the Mann-Whitney test
(p=0.003 and p=0.007, respectively). This is not surprising, given the extensive literature
investigating differences in iatrophobia by race (Washington, 2007). Interestingly, there were
virtually no racial disparities in the autopsy-derived metric (p=0.13), which is especially
unexpected given the higher rate of autopsies among African Americans.
5.2.3 Trust-based Disparities in End-of-Life Care
We hypothesize that if trust were a contributing factor to EOL treatment disparities, then
stratifying the data into low mistrust and high mistrust8 would yield an even larger disparity
than white and black.
Figure 3 shows significant disparities for both ventilation (𝑝 < 0.001) and vasopressor
(p=0.001) durations using the noncompliance-derived metric to stratify the cohort. The
difference between the medians of the mistrustful and trustful groups is 650 minutes for
vasopressors (as opposed to 200 minutes between black and white). This gap is even larger
for ventilation durations, as shown in Figure 3a: the noncompliance stratification shows a
2580-minute difference between medians, in contrast to the 832-minute gap for the race split
in Figure 2a. This threefold-increase in the treatment gap suggests that trust might be one
of the contributing factors for the original racial disparity.
For autopsy-derived mistrust, we can see that Figure 4 exhibits the same conclusions
as race-based stratifications in Figure 2: mechanical ventilation has significant disparities
(𝑝 < 0.001) whereas vasopressors do not (p= 0.059). However, just as noncompliance-based
Table 3: Top-3 most positively and negatively informative chartevent features for each
mistrust metric.
Feature Weight
state: alert -1.0156
riker-sas scale: 0.7013
agitated
pain: none -0.5427
richmond-ras scale: -0.3598
0 alert and calm
education readiness: no 0.2540
pain level: 7-mod to severe 0.2168
(a) Noncompliance-derived Mistrust
Feature Weight
pain present: no -0.2689
spokesperson is -0.2271
healthcare proxy
family communication: -0.1184
talked to m.d.
reapplied restraints 0.1153
restraint type: soft limb 0.0980
orientation: oriented 3x 0.0363
(b) Autopsy-derived Mistrust
8For each treatment, we preserve the same size difference of stratified groups in order to maintain
consistency in sample sizes for significance testing (e.g. since the black group contains 510 patients for
ventilation, we compare the 510 lowest trust patients against the 4811 highest trust patients).
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Figure 3: Noncompliance Cohort Disparities: A cohort of noncompliance-derived mis-
trust admissions yields significant differences in both ventilation and vasopressor duration.
(a)Mechanical Ventilation
High Trust: 4810 patients
Low Trust: 510 patients
𝑝 < 0.001
(b) Vasopressors
High Trust: 4456 patients
Low Trust: 453 patients
p=0.001
Figure 4: Autopsy Cohort Disparities: A cohort of autopsy-derived mistrust admissions
yields significant differences in ventilation, but a non-significant difference in vasopressor
duration.
(a)Mechanical Ventilation
High Trust: 4810 patients
Low Trust: 510 patients
p<0.001
(b) Vasopressors
High Trust: 4456 patients
Low Trust: 453 patients
p=0.059
mistrust had a threefold increase in the treatment gap, this autopsy-derived metric has a
twofold increase from the racial disparities found in ventilation (1,559 vs. 832 minutes) and
vasopressors (245 vs 106 minutes).
Negative sentiment analysis exhibits the same trend for ventilation (𝑝 < 0.001) but a
surprising result for vasopressor usage, as shown in Figure 5. There seems to be virtually
no sentiment-based difference at all in vasopressor duration (p= 0.241). In fact, even the
ventilation gap is smaller than with the other mistrust-based cohorts: 570 minutes (gaps for
noncompliance and autopsy were 2,580 and 1,559, respectively). These results show that
sentiment analysis is a bit of an outlier from the other two mistrust metrics. Nonetheless,
we believe even this metric’s results are a useful contribution for exploring the space of
algorithmically-defined trust.
5.2.4 Not Just Some Acuity Score Proxies
These mistrust metrics are typically more effective than race at stratifying the data to
show treatment disparities. However, one possible concern is the possibility that the scores
are capturing severity-of-illness rather than mistrust: certainly, high-risk patients would be
9
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Figure 5: Sentiment Cohort Disparities: A cohort of negative sentiment analysis admis-
sions yields significant differences in ventilation, but virtually no differences in vasopressor
duration.
(a)Mechanical Ventilation
High Trust: 4646 patients
Low Trust: 492 patients
𝑝 < 0.001
(b) Vasopressors
High Trust: 4284 patients
Low Trust: 427 patients
p=0.241
treated differently than the general population. To address this concern, we compare the
pairwise Pearson correlation coefficients between the three mistrust scores and two well-
established acuity scores (OASIS and SAPS II). Table 4 shows that the severity scores
have a strong correlation with one another (0.68). On the other hand, every mistrust
scores has a very weak of a correlation with these risk scores; the largest severity-mistrust
correlation being 0.086 between Sentiment and SAPS II. Interestingly, the autopsy-based
mistrust metric is actually negatively correlated with the two severity scores (i.e. sicker
patients are less likely to get autopsies) while still remaining positively correlated with the
other two mistrust metrics. The noncompliant and autopsy metrics have the strongest
intra-mistrust correlation (0.262). This is not surprising because these two metrics are both
derived from Machine Learning on the chartevents features.
5.3 Mistrust Metric is Predictive in Downstream Tasks
We demonstrate that the mistrust score captures meaningful information by evaluating its
contribution as a feature to predict three tasks: whether the patient is DNR, whether the
patient left AMA, and in-hospital mortality.
The results can be found in Table 5, which show that race and trust both improve
outcome prediction. Performance is variable across the tasks: no single feature is most
useful for all three tasks. As is often the case, combining all of the features achieves the
best results on each task — sometimes even with statistical significance, as for in-hospital
Table 4: Pairwise Pearson correlation coefficients between scores.
OASIS SAPS II Noncompliance Autopsy Sentiment
OASIS 1.0 0.679 0.050 -0.012 0.075
SAPS II 0.679 1.0 0.013 -0.013 0.086
Noncompliance 0.050 0.013 1.0 0.262 0.058
Autopsy -0.012 -0.013 0.262 1.0 0.044
Sentiment 0.075 0.086 0.058 0.044 1.0
10
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Table 5: Effect of race and mistrust features on various binary classification tasks. Perfor-
mance is measured by AUC and averaged over 100 runs.
Features Left Code In-Hospital
AMA Status Mortality
(n=48,071) (n=39,815) (n=48,071)
Baseline 0.859± .014 0.763± .013 0.600± .011
Baseline + Race 0.861± .014 0.766± .014 0.614± .011
Baseline + Noncompliant 0.869± .012 0.767± .013 0.614± .010
Baseline + Autopsy 0.861± .012 0.773± .011 0.603± .012
Baseline + Negative-Sentiment 0.859± .013 0.765± .014 0.615± .010
Baseline + ALL 0.873± .012 0.782± .012 0.635± .010
mortality. Each mistrust metric achieves the top individual performance on one of the tasks:
noncompliance-score for Left AMA, autopsy-score for Code Status, and negative-sentiment-
score for In-Hospital Mortality. Race proves itself to be a very useful feature for all three
tasks, outperforming at least one of the mistrust metrics in each category. Noncompliance-
derived mistrust proves to be the most performant mistrust metric, achieving top-2 results
for each task (excluding the ALL run).
Average classifier weights for the Baseline + ALL model are shown in Table 6. The
two features most strongly associated with in-hospital mortality were the patient’s mis-
trust scores followed by the patient’s age. This is not surprising, because the highest-
noncompliance-mistrust quartile has a 13.7% mortality rate, which is over three times as
high as the lowest-noncompliance-mistrust quartile’s 4.4% mortality rate.
We also observe that noncompliance-derived mistrust, autopsy-derived mistrust, and
race:black are the only three features positively associated with leaving the hospital AMA.
Noncompliance (average coefficient of .52) is significantly more informative than autopsy
and race:black (.01 and .03, respectively). As we saw in earlier experiments, mistrust is an
even stronger indicator than race. In general, however, race tends to be a poor predictor
for some of these outcomes because it is too coarse-grained to capture all of the different
ways healthcare delivery can fail. For most tasks, the weights of racial features add little
predictive value and are zero’d out during training. On the other hand, age is a very powerful
predictor of these various outcomes, though not consistently indicating breakdowns in the
doctor-patient relationship. While older patients are more likely to expire in-hospital, they
are less likely to leave the hospital against medical advice. The mistrust score is the only
feature positively associated with each outcome and consistently demonstrates predictive
value.
6. Conclusion
One aim of this work is to establish existing findings of racial disparities in end-of-life care on
a publicly available dataset, namely MIMIC III. We demonstrate that black patients receive
– sometimes significantly – longer durations of invasive treatments and are significantly more
likely to leave the hospital against medical advice. Though these trends have been studied
in private datasets, we present our analysis on a public dataset and make our code available.
11
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Table 6: Average regularized weights for BASELINE+ALL model on various tasks.
feature Left AMA Code Status Mortality
noncompliant 0.52± 0.09 0.27± 0.04 0.16± 0.03
autopsy 0.01± 0.03 −0.44± 0.05 0.02± 0.02
negative sentiment 0.00± 0.02 0.09± 0.03 0.16± 0.03
race: asian 0.00± 0.00 0.00± 0.00 −0.05± 0.03
race: black 0.03± 0.12 −0.22± 0.19 −0.53± 0.31
race: hispanic 0.00± 0.00 −0.17± 0.21 −0.58± 0.34
race: other −0.15± 0.19 −0.12± 0.17 0.15± 0.30
race: white −0.02± 0.06 0.06± 0.15 −0.26± 0.30
race: native american 0.00± 0.00 0.00± 0.00 0.00± 0.00
gender: male 0.00± 0.00 −0.85± 1.40 −0.67± 0.99
gender: female −0.40± 0.20 −0.49± 1.39 −0.59± 0.99
insurance: private −1.01± 0.21 −0.94± 0.29 −0.96± 0.95
insurance: public 0.00± 0.00 −0.02± 0.28 −0.50± 0.95
insurance: self-pay 0.00± 0.00 −0.02± 0.24 −0.21± 0.68
length-of-stay −1.44± 0.37 −0.70± 0.10 0.08± 0.03
age −2.10± 0.21 0.42± 0.02 0.20± 0.02
To further investigate this phenomenon, we propose multiple proxy mistrust scores using
coded interpersonal data and clinical notes. We find that stratifying patients by trust score,
instead of by race, more fully separates those patients who persist in aggressive interventions
from those who do not. We show that the mistrust scores add value to multiple predictive
tasks. While the scores partially capture racial differences (the median black patient had
higher level of mistrusts than the median white patient), it is multifaceted, and feature
analysis suggests that it captures information that agrees with our intuition of relationships
and trust.
Medical machine learning is moving forward at an exciting pace; this work is a first
step towards creating models that serve everyone, and do not propagate existing disparities
in care. This work does have shortcomings, most notably that the small datasize likely
reduced statistical power and that the mistrust metrics were approximations of an intan-
gible concept. Each metric had its flaws: there are non-trust-based reasons why a patient
might be noncompliant (e.g. couldn’t afford to refill their prescription), not all autopsies
suggest skepticism of the doctor’s performance, and although sentiment is a related concept
it is ultimately not the same thing as trust. We encourage forming inter-disciplinary col-
laborations among machine learning, healthcare, and social science communities to refine
algorithmic notions of mistrust, quantify potential biases and disparities in models, and
identify potential factors that lead to patient dissatisfaction.
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